CSF2 and hepatocellular carcinoma: Recent studies have shown that HCC and gastric cancer-derived GM-CSF bind neutrophil receptors and stimulate JAK2 and STAT3 phosphorylation that promotes expression of PD-L1 on the neutrophil surface, which binds and inhibits PD-1 on cytotoxic T cells [82,83,84].